Abstract:Chimeric antigen receptor T cell (CAR-T) therapy is a late-model of immune cell therapy that has been shown to be effective in refractory/recurrent B-cell leukemia and lymphoma. Compared with the traditional anti-tumor methods, CAR-T cell therapy has the advantages of higher specificity, stronger lethality and longer-lasting efficacy. Although CAR-T cells have made significant progress in the treatment of hematologic malignancies, diverse difficulties remain in the treatment of solid tumors, including immune escape due to tumor antigen heterogeneity, preventing entry or limiting the persistence of CAR-T cells by physical or cytokine barriers and along with other immunosuppressive molecule and cells in the tumor microenvironment (TME). Otherwise, the intracellular signaling of CAR also impact on CAR-T cells persistence. Appropriate modification of intracellular costimulatory molecular signal in the structure of CAR or coexpression of CAR and cytokines can provide a way to enhance CAR-T cells activity. Additionally, CAR-T cells dysfunction due to T cell exhaustion is associated with multi-factors, especially transcription factors, such as c-Jun, NR4A. Engineering CAR-T cells to coexpress or knockout transcription factors in favor of T<sub>CM</sub> memory CAR-T cells differentiation was proved to prolonged the survival of CAR-T cells. Finally, combination of CAR-T cells with oncolytic viruses, nanoparticles or immune checkpoint inhibitors provides an effective measure to improve CAR-T cells function. Here, we discuss all of these advances and challenges and review promising strategies for treating solid tumors. In particular, we also highlight that CAR-T cells have enormous potential to be used in combination with other immunotherapies.

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

CAR‐T Therapy in Clinical Practice: Technical Advances and Current Challenges

Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy

CAR-T in solid tumors: Blazing a new trail through the brambles

Extant challenges and optimization strategies for CAR-T cell therapy for solid tumors

Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies

CAR-T Treatment for Cancer: Prospects and Challenges

Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies

Current progress in CAR-T cell therapy for tumor treatment

Challenges and optimal strategies of CAR T therapy for hematological malignancies.

Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies

CAR‐T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)

Innovative Strategies to Advance CAR T Cell Therapy for Solid Tumors.

Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR-T) cell immunotherapy

CAR-T cell therapy: current limitations and potential strategies

Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy

The progress of CAR-T therapy in cancer and beyond

Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers

CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead

Recent Progress in Improving the Safety and Efficacy of Chimeric Antigen Receptor T Cell Therapy

Challenges and innovations in CAR-T cell therapy: a comprehensive analysis